Emery Pharma and Rayner Announce Publication of a Successful Validation of Bioanalytical Method for Quantifying Ketorolac in Human Vitreous and Aqueous Humor Using a Surrogate Matrix of Human Plasma, in Accordance with ICH M10 Guidelines
Emery Pharma, a leading contract research organization specializing in bioanalytical method development and validation, has partnered with Rayner to develop and validate a novel bioanalytical method for measuring ketorolac concentrations…
Emery Pharma Sponsors PDA Event on Artificial Intelligence in Biopharmaceutical Development and Manufacturing
Alameda, CA – Emery Pharma, a leader in analytical testing and research services, is proud to announce its sponsorship of the upcoming Parenteral Drug Association (PDA) event, Artificial Intelligence in…
Centivax and Emery Pharma Partner to Accelerate Universal Vaccine Clinical Readiness
Centivax, a biotechnology company that develops broad-spectrum vaccines to combat rapidly evolving pathogens, has announced a strategic collaboration with Emery Pharma, a leading contract research organization specializing in GLP/cGMP compliant…
Emery Pharma and AbVacc Announce Strategic Collaboration to Develop Super Fast-Acting Intranasal Naloxone
San Francisco, CA, and Rockville, MD –Emery Pharma, a leading pharmaceutical research organization in the San Francisco Bay Area, and AbVacc, a renowned biotechnology company headquartered in Rockville, Maryland, are…
Emery Pharma Attending 2025 J.P. Morgan 43rd Annual Healthcare Conference
ALAMEDA, CA – Emery Pharma has announced that CEO, Ron Najafi, Ph.D., and the Business Development team will be available during the JP Morgan Annual Healthcare Conference, held on January 13…
Emery Pharma to Attend the Annual ACT Meeting in Austin Texas
Emery Pharma, a leading contract research organization (CRO) based in Alameda, CA, specializing in pharmaceutical and biotechnology solutions, is pleased to announce its attendance at the upcoming American College of…
Emery Pharma Offers Support to Pharmaceutical Companies Following FDA’s Duloxetine Recall Due to Nitrosamine Impurities
In light of the recent FDA recall of duloxetine, a widely used antidepressant, due to the detection of nitrosamine impurities, Emery Pharma is offering its expertise to pharmaceutical companies facing…
Emery Pharma to Sponsor Chinese American BioPharmaceutical Society (CABS) Workshop
Emery Pharma is excited to announce its sponsorship of Chinese American Biopharmaceutical Society’s (CABS) upcoming workshop, “Journey from Discovery to IND to Early Development”, taking place on November 9, 2024,…
Emery Pharma Attending the American Academy of Ophthalmology (AAO) Annual Meeting 2024
Emery Pharma is proud to announce that their CEO, Dr. Ron Najafi and CMO, Dr. Kathryn Najafi-Tagol, the inventors of Avenova®, the leading product to treat dry eye due to…
Our Poster to be Recognized at AAPS 2024 PharmSci 360
Emery Pharma is thrilled to announce that our scientific poster, titled “LC-MS/MS Method for the Quantitation of Each Monoclonal Antibody (from a 6-Components Antibody Cocktail Drug Product) in Human Serum…